These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 9844991

  • 1. Effects of thromboxane A2 antagonist on airway hyperresponsiveness, exhaled nitric oxide, and induced sputum eosinophils in asthmatics.
    Aizawa H, Inoue H, Nakano H, Matsumoto K, Yoshida M, Fukuyama S, Koto H, Hara N.
    Prostaglandins Leukot Essent Fatty Acids; 1998 Sep; 59(3):185-90. PubMed ID: 9844991
    [Abstract] [Full Text] [Related]

  • 2. The effect of seratrodast on eosinophil cationic protein and symptoms in asthmatics.
    Fukuoka T, Miyake S, Umino T, Inase N, Tojo N, Yoshizawa Y.
    J Asthma; 2003 May; 40(3):257-64. PubMed ID: 12807169
    [Abstract] [Full Text] [Related]

  • 3. [Correlation between the clinical effects of Seratrodast and the level of 11-dehydrothromboxane B2 in urine/sputum in bronchial asthma patients].
    Muramatsu H, Kotajima R, Sato T.
    Arerugi; 2001 Jun; 50(6):540-6. PubMed ID: 11517517
    [Abstract] [Full Text] [Related]

  • 4. Exhaled nitric oxide continues to reflect airway hyperresponsiveness and disease activity in inhaled corticosteroid-treated adult asthmatic patients.
    Reid DW, Johns DP, Feltis B, Ward C, Walters EH.
    Respirology; 2003 Dec; 8(4):479-86. PubMed ID: 14629652
    [Abstract] [Full Text] [Related]

  • 5. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma.
    Horváth I, Donnelly LE, Kiss A, Kharitonov SA, Lim S, Chung KF, Barnes PJ.
    Am J Respir Crit Care Med; 1998 Oct; 158(4):1042-6. PubMed ID: 9769258
    [Abstract] [Full Text] [Related]

  • 6. [Thromboxane A2 antagonist--discovery of seratrodast].
    Terao S, Shiraishi M, Matsumoto T, Ashida Y.
    Yakugaku Zasshi; 1999 May; 119(5):377-90. PubMed ID: 10375998
    [Abstract] [Full Text] [Related]

  • 7. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma.
    van Rensen EL, Straathof KC, Veselic-Charvat MA, Zwinderman AH, Bel EH, Sterk PJ.
    Thorax; 1999 May; 54(5):403-8. PubMed ID: 10212103
    [Abstract] [Full Text] [Related]

  • 8. Baseline airway hyperresponsiveness and its reversible component: role of airway inflammation and airway calibre.
    Ichinose M, Takahashi T, Sugiura H, Endoh N, Miura M, Mashito Y, Shirato K.
    Eur Respir J; 2000 Feb; 15(2):248-53. PubMed ID: 10706487
    [Abstract] [Full Text] [Related]

  • 9. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma.
    Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ.
    Thorax; 1998 Feb; 53(2):91-5. PubMed ID: 9624291
    [Abstract] [Full Text] [Related]

  • 10. Sputum eosinophil count in a large population of patients with mild to moderate steroid-naive asthma: distribution and relationship with methacholine bronchial hyperresponsiveness.
    Louis R, Sele J, Henket M, Cataldo D, Bettiol J, Seiden L, Bartsch P.
    Allergy; 2002 Oct; 57(10):907-12. PubMed ID: 12269936
    [Abstract] [Full Text] [Related]

  • 11. Effects of KP-496, a novel dual antagonist at the cysteinyl leukotriene receptor 1 and the thromboxane A(2) receptor, on airway obstruction in guinea pigs.
    Ishimura M, Suda M, Morizumi K, Kataoka S, Maeda T, Kurokawa S, Hiyama Y.
    Br J Pharmacol; 2008 Feb; 153(4):669-75. PubMed ID: 18037905
    [Abstract] [Full Text] [Related]

  • 12. Effect of leukotriene and thromboxane antagonist on propranolol-induced bronchoconstriction.
    Fujimura M, Abo M, Kamio Y, Myou S, Ishiura Y, Hashimoto T, Matsuda T.
    Am J Respir Crit Care Med; 1999 Dec; 160(6):2100-3. PubMed ID: 10588635
    [Abstract] [Full Text] [Related]

  • 13. Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma.
    Leuppi JD, Salome CM, Jenkins CR, Koskela H, Brannan JD, Anderson SD, Andersson M, Chan HK, Woolcock AJ.
    Eur Respir J; 2001 Sep; 18(3):444-50. PubMed ID: 11589340
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Exhaled nitric oxide following leukotriene E(4) and methacholine inhalation in patients with asthma.
    Deykin A, Belostotsky O, Hong C, Massaro AF, Lilly CM, Israel E.
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1685-9. PubMed ID: 11069797
    [Abstract] [Full Text] [Related]

  • 16. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma.
    Dupont LJ, Rochette F, Demedts MG, Verleden GM.
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):894-8. PubMed ID: 9517608
    [Abstract] [Full Text] [Related]

  • 17. [Thromboxane A2 synthase inhibitor and receptor antagonist].
    Minoguchi K, Adachi M.
    Nihon Rinsho; 2001 Oct; 59(10):1986-91. PubMed ID: 11676143
    [Abstract] [Full Text] [Related]

  • 18. Effects of selective COX-2 inhibition on allergen-induced bronchoconstriction and airway inflammation in asthma.
    Daham K, James A, Balgoma D, Kupczyk M, Billing B, Lindeberg A, Henriksson E, FitzGerald GA, Wheelock CE, Dahlén SE, Dahlén B.
    J Allergy Clin Immunol; 2014 Aug; 134(2):306-13. PubMed ID: 24461582
    [Abstract] [Full Text] [Related]

  • 19. Characteristics of asthma resistant to moderate dose inhaled corticosteroid treatment on bronchial hyperresponsiveness.
    Fujimoto K, Yamaguchi S, Urushibata K, Hanaoka M, Koizumi T, Honda T, Kubo K.
    Intern Med; 2006 Aug; 45(14):843-9. PubMed ID: 16908940
    [Abstract] [Full Text] [Related]

  • 20. Relationship between airway responsiveness to mannitol and to methacholine and markers of airway inflammation, peak flow variability and quality of life in asthma patients.
    Porsbjerg C, Brannan JD, Anderson SD, Backer V.
    Clin Exp Allergy; 2008 Jan; 38(1):43-50. PubMed ID: 18028458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.